icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Illinois Legalizes Industrial Hemp

By Larry Mishkin, Hoban Law Group, Litigation Practice Group Counsel Last month, Illinois Gov. Bruce Rauner signed into law Senate Bill 2298, the Illinois Industrial Hemp Act, which became effective immediately. The act allows Illinois farmers, in conjunction with a university or other recognized research group, to cultivate industrial hemp for research and commercial purposes. […]
Read more

Cannabis Research Efforts Progressing Despite Federal Tax and Banking Regulations

By Michael Harlow and Craig Golding Partners at CohnReznick There are some unique challenges to conducting research in the United States on the medical applications of cannabis. Cannabis’ federal Schedule I classification presents several obstacles for cannabis industry operators and businesses, even for those located in states where medical and recreational use is legal. Strict [...]
Read more

States Challenged to Optimize Cannabis Tax Revenues

Some reinventing the cannabis tax-reform wheel as they go along By Tracy Curley, Partner at Cohnreznick The legal status of cannabis presents a challenge toward advancements in quality assurance and medical research. Currently, the Controlled Substance Act carries no distinction between the medical and recreational uses of cannabis, which is classified as a Schedule I […]
Read more

States Challenged to Optimize Cannabis Tax Revenues

Some reinventing the cannabis tax-reform wheel as they go along By Bob Moss, Principal, National Director of Governmental Affairs & Eddie Delgado, CMI, Cohn Reznick For the states with cannabis initiatives on the ballot this fall, there is a fine line between passing legislation and being prepared to implement the new law. With time and more […]
Read more

Growth Strategy for the Green Ocean

Setting a new path for market entry into the cannabis industry Cannabis operators who want to shape the future of legal consumption in the United States want to create innovative new products, reach broad new customer sets, and promote positive uses for cannabis to meet the $80 billion market opportunity the industry is chasing. While cannabis […]
Read more

Up in Smoke: Alpenglow Botanicals, LLC V. United States

Challenging IRS authority to deny “ordinary and necessary” business expense deductions By Tosin Hassan, CPA, CohnReznick In the words of Lauryn Hill, “It’s funny how money changes a situation, miscommunication leads to complication.” With the explosion of cannabis businesses across the country, many business owners are not profitable because of significant tax bills impacting cannabis […]
Read more

Beware! Are you in compliance with your cash payments?

By Mary Amato, CPA, Partner, CohnReznick It is no secret that the Internal Revenue Service (IRS) is aggressively auditing cannabis businesses. The focus is on more than the limitations placed on the industry by IRC §280E. The IRS aggressively audits non-compliance of Reporting of Cash Payments. Form 8300, is not an income tax reporting form. […]
Read more

Acquisition-Side Due Diligence in The Legal Cannabis Industry: Approach and Expectations for Both Sides

By Greg Chin, Kevin Michaelan and Jeffrey Michelson, Partner Continuing with the topic of industry trends from our last post, we explore the art of acquisition-side due diligence from full-scope financial and tax to limited-scope tax-only engagements.  We’ll look at what to expect and how to approach it.  Although commonly geared toward the investor/acquirer, i.e., […]
Read more

Cost Segregation and Benefits for Real Estate Investors

What We Learned: Operators owning property types which have a tax basis of at least $1 million, and that are subject to depreciation, can qualify for a cost segregation study (CSS). By Derek Weaver, Senior Manager As discussed in December 2017, 280E continues to be a major problem for plant-touching businesses. However, there are several […]
Read more

How to Evaluate Valuations in the Cannabis Marketplace

By Andrew Lines, MAI, Principal What We Have Learned: In valuing the business operations of companies in the cannabis industry, risk is a significant factor that can dampen even the most optimistic outlook and projections. Valuations within the growing cannabis industry don’t always seem to be consistent with operator or investor expectations; this can be […]
Read more